マルチオミクスの世界市場規模、シェア、産業動向分析レポート：タイプ別、製品・サービス別、最終用途別、プラットフォーム別、用途別、地域別展望・予測、2023年～2030年

マルチオミクス市場規模は2030年までに57億米ドルに達すると予測され、予測期間中のCAGRは15.0%の市場成長率で上昇する見込みです。

KBV Cardinalのマトリックスに掲載された分析によると、Danaher CorporationとThermo Fisher Scientific, Inc.が同市場の先行企業です。Bruker Corporation、Illumina, Inc.、Becton Dickinson and Companyなどの企業は、市場における主要なイノベーターです。2022年1月、Illumina, Inc.はタンパク質バイオマーカー探索と臨床診断のSomaLogicと提携しました。この提携は、プロテオミクス市場で急成長しているハイスループット分野を急成長させることを目的としています。

市場成長要因

ハイスループット・オミクス技術の進歩の高まり

ハイスループット・オミクス技術は、データ生成コストを大幅に削減しました。この費用対効果により、マルチオミクス研究へのアクセスが民主化され、より幅広い研究者、研究機関、企業にとって手頃な価格となっています。その結果、より多くの企業が市場に参入し、イノベーションと競争が促進されています。潜在的なバイオマーカーや治療標的を同定するためには、このレベルの詳細さが不可欠です。参入障壁が低くなったことで、オミクス技術やサービスを専門とする新興企業や企業のエコシステムが活発化しています。これらの要因は、将来の需要を押し上げると予想されます。

世界中で高まる個別化医療の需要

個別化医療の重視は、ヘルスケアプロバイダーや研究者にマルチオミクス技術の活用を促します。これにはゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクスが含まれ、個人の分子および遺伝的構成に関する包括的な洞察を提供します。このような利用の増加は、マルチオミクスのサービスやソリューションに対する需要の拡大につながります。マルチオミクスデータは、患者の遺伝的素因、バイオマーカープロファイル、疾患リスクを詳細に理解することができます。この統合がマルチオミクス技術とサービスの需要を押し上げます。個別化医療におけるこうしたデータの需要は、革新的な新興企業や既存企業に専門的なサービスや技術を提供する機会を生み出しています。したがって、これらの要因は、今後数年間の市場拡大を促進すると思われます。

市場抑制要因

継続的に進化するマルチオミクスの規制環境

データの共有は、科学的共同研究やマルチオミクス研究の進展に不可欠です。しかし、患者のプライバシー保護や規制遵守の必要性から、データの共有範囲が制限される場合があります。これは共同研究の妨げとなり、マルチオミクスデータセットの利用を制限する可能性があります。規制の変更は頻繁で予測不可能な場合があります。この市場の組織は、進化する規制を継続的に監視し、適応していかなければならないです。規制の変化により、データの取り扱い、調査手法、ビジネスモデルの変更が必要になることもあります。これらの要因は、今後数年間の同市場の成長を制限すると予想されます。

タイプ別展望

タイプ別に見ると、市場はシングルセル・マルチオミクスとバルク・マルチオミクスに分けられます。バルクマルチオミクスセグメントは、2022年の市場において最大の収益シェアを記録しました。洗練されたバイオインフォマティクスツールとデータ統合プラットフォームが利用可能になったことで、バルクマルチオミクスデータの解析と解釈が容易になっています。研究者は現在、比較的容易にクロスオミクス解析を実行し、異なるデータタイプ間の相関関係やパターンを特定することができます。バルクマルチオミクスは、精密医療の進歩において極めて重要な役割を果たしています。個人のマルチオミクス・プロファイルを分析することで、臨床医はその人特有の分子特性に合わせた治療を行うことができます。このアプローチは、患者の転帰を改善し、副作用を軽減する上で大きな可能性を秘めています。このような要因から、バルクマルチオミクス分野での需要が増加すると思われます。

製品とサービスの展望

製品・サービスに基づき、市場は製品とサービスに区分されます。2022年には、サービス分野が市場で大きな収益シェアを獲得しました。ハイスループットなオミクス技術の継続的な開発により、膨大なデータの生成が可能になっています。しかし、このデータを分析するには専門的な知識が必要であるため、専門プロバイダーが提供するサービスへの依存度が高まっています。マルチオミクス・データは本質的に複雑で、多数の変数や相互作用が存在します。このデータの解釈には、高度なバイオインフォマティクスと計算ツールが必要であり、データ解析と解釈のソリューションを提供するサービスプロバイダーのニッチを生み出しています。これらの要因によって、サービス分野での需要が促進されると予想されます。

製品の展望

製品セグメントはさらに機器、消耗品、ソフトウェアに細分化されます。2022年には、機器サブセグメントが市場で最も高い収益シェアを獲得しました。次世代シーケンシング（NGS）プラットフォームは、シーケンシング能力、リード長、データ品質において目覚ましい進歩を遂げています。これらの改善により、ゲノムおよびトランスクリプトミクス研究へのNGSの採用が増加しています。質量分析技術はより高感度になり、より幅広い分子を分析できるようになっています。これにより、プロテオミクスやメタボロミクス研究での利用が拡大しています。

最終用途の展望

最終用途別に見ると、市場は学術・研究機関、製薬・バイオテクノロジー企業、その他に分けられます。学術・研究機関セグメントは、2022年の市場で最大の収益シェアを記録しました。学術・研究機関は、政府筋や民間財団からの研究資金提供の増加から恩恵を受けています。資金提供機関は、科学的知識を進歩させ、複雑な健康や環境の課題に取り組む上で、マルチオミクス研究の重要性を認識しています。このような資金提供の増加により、学術研究機関はマルチオミクス研究のイニシアチブを拡大することができるようになっています。

プラットフォームの展望

プラットフォーム別に見ると、市場はゲノミクス、トランスクリプトミクス、プロテオミクス、メタボロミクス、統合オミクスプラットフォームに区分されます。プロテオミクス分野は、2022年の市場で有望な成長率を確保しました。プロテオミクス・プラットフォームはタンパク質の機能を決定することができ、これは様々な生物学的プロセスにおけるタンパク質の役割を理解する上で極めて重要です。この情報は、基礎研究や応用科学にとって貴重です。プロテオミクス解析は、治療標的となるタンパク質の同定にも役立ちます。バイオ医薬品などの産業では、プロテオミクスプラットフォームは製品の一貫性と安全性を確保するための品質管理に使用されます。

用途の展望

用途別に見ると、市場は細胞生物学、腫瘍学、神経学、免疫学に分けられます。細胞生物学セグメントは、2022年のマルチオミクス市場で最大の収益シェアを記録しました。細胞生物学は、マルチオミクスと連携して、がん研究と精密腫瘍学において重要な役割を果たしています。研究者たちは、がん細胞の分子変化をかつてないほど詳細にプロファイリングできるようになっています。このことは、新たな薬物標的の発見、標的療法の開発、耐性メカニズムの特定につながっています。また、がん治療レジメンの個別化にも貢献し、患者の転帰を改善しています。このような要因から、同分野の需要は高まると思われます。

地域別展望

地域別に見ると、市場は北米、欧州、アジア太平洋、LAMEAに区分されます。北米セグメントは、2022年の市場で最も高い収益シェアを獲得しました。北米は、マルチオミクス研究の最前線に立つ一流大学、学術機関、研究機関を擁し、強固で資金力のある研究エコシステムを誇っています。これらの機関は研究を推進し、画期的な研究成果を発表し、多額の研究資金を集めています。従って、この分野での需要は増加すると思われます。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
• 調査手法

第2章 市場の概要

• 主なハイライト

第3章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第4章 競合分析- 世界

• KBV Cardinal Matrix
• 最近の業界全体の戦略的展開
  • パートナーシップ、コラボレーション、および契約
  • 製品の発売と製品の拡大
  • 買収と合併
  • 地理的拡大
• 主要成功戦略
  • 主な戦略
  • 主要な戦略的動き
• ポーターのファイブフォース分析

第5章 世界のマルチオミクス市場：タイプ別

• 世界のバルクマルチオミクス市場：地域別
• 世界の単一細胞マルチオミクス市場：地域別

第6章 世界のマルチオミクス市場：製品とサービス別

• 世界の製品市場：地域別
• 世界のマルチオミクス市場：製品タイプ別
  • 世界の計測器市場：地域別
  • 世界の消耗品市場：地域別
  • 世界のソフトウェア市場：地域別
• 世界サービス市場：地域別

第7章 世界のマルチオミクス市場：最終用途別

• 世界の学術研究機関市場：地域別
• 世界の製薬およびバイオテクノロジー企業市場：地域別
• 世界のその他の市場：地域別

第8章 世界のマルチオミクス市場：プラットフォーム別

• 世界のゲノミクス市場：地域別
• 世界のトランスクリプトミクス市場：地域別
• 世界のプロテオミクス市場：地域別
• 世界のメタボロミクス市場：地域別
• 世界の統合オミクスプラットフォーム市場：地域別

第9章 世界のマルチオミクス市場：用途別

• 世界の細胞生物学市場：地域別
• 世界の腫瘍学市場：地域別
• 世界の神経学市場：地域別
• 世界の免疫学市場：地域別

第10章 世界のマルチオミクス市場：地域別

• 北米
  • 北米の市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州地域
• アジア太平洋
  • アジア太平洋の市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• ラテンアメリカ・中東・アフリカ
  • ラテンアメリカ・中東・アフリカの市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • その他ラテンアメリカ・中東・アフリカ地域

第11章 企業プロファイル

• Thermo Fisher Scientific, Inc
• Illumina, Inc
• Danaher Corporation
• PerkinElmer, Inc
• Bruker Corporation
• Qiagen NV
• Agilent Technologies, Inc
• BGI Group
• Becton, Dickinson, and Company
• Shimadzu Corporation

第12章 市場の成功必須条件

LIST OF TABLES

• TABLE 1 Global Multiomics Market, 2019 - 2022, USD Million
• TABLE 2 Global Multiomics Market, 2023 - 2030, USD Million
• TABLE 3 Partnerships, Collaborations and Agreements- Multiomics Market
• TABLE 4 Product Launches And Product Expansions- Multiomics Market
• TABLE 5 Acquisition and Mergers- Multiomics Market
• TABLE 6 Geographical Expansions- Multiomics Market
• TABLE 7 Global Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 8 Global Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 9 Global Bulk Multiomics Market by Region, 2019 - 2022, USD Million
• TABLE 10 Global Bulk Multiomics Market by Region, 2023 - 2030, USD Million
• TABLE 11 Global Single-cell Multiomics Market by Region, 2019 - 2022, USD Million
• TABLE 12 Global Single-cell Multiomics Market by Region, 2023 - 2030, USD Million
• TABLE 13 Global Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 14 Global Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 15 Global Product Market by Region, 2019 - 2022, USD Million
• TABLE 16 Global Product Market by Region, 2023 - 2030, USD Million
• TABLE 17 Global Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 18 Global Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 19 Global Instruments Market by Region, 2019 - 2022, USD Million
• TABLE 20 Global Instruments Market by Region, 2023 - 2030, USD Million
• TABLE 21 Global Consumables Market by Region, 2019 - 2022, USD Million
• TABLE 22 Global Consumables Market by Region, 2023 - 2030, USD Million
• TABLE 23 Global Software Market by Region, 2019 - 2022, USD Million
• TABLE 24 Global Software Market by Region, 2023 - 2030, USD Million
• TABLE 25 Global Services Market by Region, 2019 - 2022, USD Million
• TABLE 26 Global Services Market by Region, 2023 - 2030, USD Million
• TABLE 27 Global Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 28 Global Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 29 Global Academic & Research Institutes Market by Region, 2019 - 2022, USD Million
• TABLE 30 Global Academic & Research Institutes Market by Region, 2023 - 2030, USD Million
• TABLE 31 Global Pharmaceutical & Biotechnology Companies Market by Region, 2019 - 2022, USD Million
• TABLE 32 Global Pharmaceutical & Biotechnology Companies Market by Region, 2023 - 2030, USD Million
• TABLE 33 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 34 Global Others Market by Region, 2023 - 2030, USD Million
• TABLE 35 Global Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 36 Global Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 37 Global Genomics Market by Region, 2019 - 2022, USD Million
• TABLE 38 Global Genomics Market by Region, 2023 - 2030, USD Million
• TABLE 39 Global Transcriptomics Market by Region, 2019 - 2022, USD Million
• TABLE 40 Global Transcriptomics Market by Region, 2023 - 2030, USD Million
• TABLE 41 Global Proteomics Market by Region, 2019 - 2022, USD Million
• TABLE 42 Global Proteomics Market by Region, 2023 - 2030, USD Million
• TABLE 43 Global Metabolomics Market by Region, 2019 - 2022, USD Million
• TABLE 44 Global Metabolomics Market by Region, 2023 - 2030, USD Million
• TABLE 45 Global Integrated Omics Platforms Market by Region, 2019 - 2022, USD Million
• TABLE 46 Global Integrated Omics Platforms Market by Region, 2023 - 2030, USD Million
• TABLE 47 Global Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 48 Global Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 49 Global Cell Biology Market by Region, 2019 - 2022, USD Million
• TABLE 50 Global Cell Biology Market by Region, 2023 - 2030, USD Million
• TABLE 51 Global Oncology Market by Region, 2019 - 2022, USD Million
• TABLE 52 Global Oncology Market by Region, 2023 - 2030, USD Million
• TABLE 53 Global Neurology Market by Region, 2019 - 2022, USD Million
• TABLE 54 Global Neurology Market by Region, 2023 - 2030, USD Million
• TABLE 55 Global Immunology Market by Region, 2019 - 2022, USD Million
• TABLE 56 Global Immunology Market by Region, 2023 - 2030, USD Million
• TABLE 57 Global Multiomics Market by Region, 2019 - 2022, USD Million
• TABLE 58 Global Multiomics Market by Region, 2023 - 2030, USD Million
• TABLE 59 North America Multiomics Market, 2019 - 2022, USD Million
• TABLE 60 North America Multiomics Market, 2023 - 2030, USD Million
• TABLE 61 North America Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 62 North America Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 63 North America Bulk Multiomics Market by Region, 2019 - 2022, USD Million
• TABLE 64 North America Bulk Multiomics Market by Region, 2023 - 2030, USD Million
• TABLE 65 North America Single-cell Multiomics Market by Region, 2019 - 2022, USD Million
• TABLE 66 North America Single-cell Multiomics Market by Region, 2023 - 2030, USD Million
• TABLE 67 North America Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 68 North America Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 69 North America Product Market by Country, 2019 - 2022, USD Million
• TABLE 70 North America Product Market by Country, 2023 - 2030, USD Million
• TABLE 71 North America Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 72 North America Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 73 North America Instruments Market by Country, 2019 - 2022, USD Million
• TABLE 74 North America Instruments Market by Country, 2023 - 2030, USD Million
• TABLE 75 North America Consumables Market by Country, 2019 - 2022, USD Million
• TABLE 76 North America Consumables Market by Country, 2023 - 2030, USD Million
• TABLE 77 North America Software Market by Country, 2019 - 2022, USD Million
• TABLE 78 North America Software Market by Country, 2023 - 2030, USD Million
• TABLE 79 North America Services Market by Country, 2019 - 2022, USD Million
• TABLE 80 North America Services Market by Country, 2023 - 2030, USD Million
• TABLE 81 North America Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 82 North America Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 83 North America Academic & Research Institutes Market by Country, 2019 - 2022, USD Million
• TABLE 84 North America Academic & Research Institutes Market by Country, 2023 - 2030, USD Million
• TABLE 85 North America Pharmaceutical & Biotechnology Companies Market by Country, 2019 - 2022, USD Million
• TABLE 86 North America Pharmaceutical & Biotechnology Companies Market by Country, 2023 - 2030, USD Million
• TABLE 87 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 88 North America Others Market by Country, 2023 - 2030, USD Million
• TABLE 89 North America Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 90 North America Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 91 North America Genomics Market by Country, 2019 - 2022, USD Million
• TABLE 92 North America Genomics Market by Country, 2023 - 2030, USD Million
• TABLE 93 North America Transcriptomics Market by Country, 2019 - 2022, USD Million
• TABLE 94 North America Transcriptomics Market by Country, 2023 - 2030, USD Million
• TABLE 95 North America Proteomics Market by Country, 2019 - 2022, USD Million
• TABLE 96 North America Proteomics Market by Country, 2023 - 2030, USD Million
• TABLE 97 North America Metabolomics Market by Country, 2019 - 2022, USD Million
• TABLE 98 North America Metabolomics Market by Country, 2023 - 2030, USD Million
• TABLE 99 North America Integrated Omics Platforms Market by Country, 2019 - 2022, USD Million
• TABLE 100 North America Integrated Omics Platforms Market by Country, 2023 - 2030, USD Million
• TABLE 101 North America Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 102 North America Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 103 North America Cell Biology Market by Country, 2019 - 2022, USD Million
• TABLE 104 North America Cell Biology Market by Country, 2023 - 2030, USD Million
• TABLE 105 North America Oncology Market by Country, 2019 - 2022, USD Million
• TABLE 106 North America Oncology Market by Country, 2023 - 2030, USD Million
• TABLE 107 North America Neurology Market by Country, 2019 - 2022, USD Million
• TABLE 108 North America Neurology Market by Country, 2023 - 2030, USD Million
• TABLE 109 North America Immunology Market by Country, 2019 - 2022, USD Million
• TABLE 110 North America Immunology Market by Country, 2023 - 2030, USD Million
• TABLE 111 North America Multiomics Market by Country, 2019 - 2022, USD Million
• TABLE 112 North America Multiomics Market by Country, 2023 - 2030, USD Million
• TABLE 113 US Multiomics Market, 2019 - 2022, USD Million
• TABLE 114 US Multiomics Market, 2023 - 2030, USD Million
• TABLE 115 US Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 116 US Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 117 US Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 118 US Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 119 US Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 120 US Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 121 US Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 122 US Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 123 US Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 124 US Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 125 US Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 126 US Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 127 Canada Multiomics Market, 2019 - 2022, USD Million
• TABLE 128 Canada Multiomics Market, 2023 - 2030, USD Million
• TABLE 129 Canada Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 130 Canada Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 131 Canada Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 132 Canada Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 133 Canada Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 134 Canada Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 135 Canada Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 136 Canada Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 137 Canada Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 138 Canada Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 139 Canada Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 140 Canada Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 141 Mexico Multiomics Market, 2019 - 2022, USD Million
• TABLE 142 Mexico Multiomics Market, 2023 - 2030, USD Million
• TABLE 143 Mexico Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 144 Mexico Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 145 Mexico Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 146 Mexico Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 147 Mexico Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 148 Mexico Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 149 Mexico Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 150 Mexico Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 151 Mexico Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 152 Mexico Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 153 Mexico Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 154 Mexico Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 155 Rest of North America Multiomics Market, 2019 - 2022, USD Million
• TABLE 156 Rest of North America Multiomics Market, 2023 - 2030, USD Million
• TABLE 157 Rest of North America Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 158 Rest of North America Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 159 Rest of North America Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 160 Rest of North America Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 161 Rest of North America Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 162 Rest of North America Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 163 Rest of North America Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 164 Rest of North America Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 165 Rest of North America Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 166 Rest of North America Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 167 Rest of North America Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 168 Rest of North America Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 169 Europe Multiomics Market, 2019 - 2022, USD Million
• TABLE 170 Europe Multiomics Market, 2023 - 2030, USD Million
• TABLE 171 Europe Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 172 Europe Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 173 Europe Bulk Multiomics Market by Country, 2019 - 2022, USD Million
• TABLE 174 Europe Bulk Multiomics Market by Country, 2023 - 2030, USD Million
• TABLE 175 Europe Single-cell Multiomics Market by Country, 2019 - 2022, USD Million
• TABLE 176 Europe Single-cell Multiomics Market by Country, 2023 - 2030, USD Million
• TABLE 177 Europe Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 178 Europe Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 179 Europe Product Market by Country, 2019 - 2022, USD Million
• TABLE 180 Europe Product Market by Country, 2023 - 2030, USD Million
• TABLE 181 Europe Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 182 Europe Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 183 Europe Instruments Market by Country, 2019 - 2022, USD Million
• TABLE 184 Europe Instruments Market by Country, 2023 - 2030, USD Million
• TABLE 185 Europe Consumables Market by Country, 2019 - 2022, USD Million
• TABLE 186 Europe Consumables Market by Country, 2023 - 2030, USD Million
• TABLE 187 Europe Software Market by Country, 2019 - 2022, USD Million
• TABLE 188 Europe Software Market by Country, 2023 - 2030, USD Million
• TABLE 189 Europe Services Market by Country, 2019 - 2022, USD Million
• TABLE 190 Europe Services Market by Country, 2023 - 2030, USD Million
• TABLE 191 Europe Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 192 Europe Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 193 Europe Academic & Research Institutes Market by Country, 2019 - 2022, USD Million
• TABLE 194 Europe Academic & Research Institutes Market by Country, 2023 - 2030, USD Million
• TABLE 195 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2019 - 2022, USD Million
• TABLE 196 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2023 - 2030, USD Million
• TABLE 197 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 198 Europe Others Market by Country, 2023 - 2030, USD Million
• TABLE 199 Europe Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 200 Europe Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 201 Europe Genomics Market by Country, 2019 - 2022, USD Million
• TABLE 202 Europe Genomics Market by Country, 2023 - 2030, USD Million
• TABLE 203 Europe Transcriptomics Market by Country, 2019 - 2022, USD Million
• TABLE 204 Europe Transcriptomics Market by Country, 2023 - 2030, USD Million
• TABLE 205 Europe Proteomics Market by Country, 2019 - 2022, USD Million
• TABLE 206 Europe Proteomics Market by Country, 2023 - 2030, USD Million
• TABLE 207 Europe Metabolomics Market by Country, 2019 - 2022, USD Million
• TABLE 208 Europe Metabolomics Market by Country, 2023 - 2030, USD Million
• TABLE 209 Europe Integrated Omics Platforms Market by Country, 2019 - 2022, USD Million
• TABLE 210 Europe Integrated Omics Platforms Market by Country, 2023 - 2030, USD Million
• TABLE 211 Europe Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 212 Europe Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 213 Europe Cell Biology Market by Country, 2019 - 2022, USD Million
• TABLE 214 Europe Cell Biology Market by Country, 2023 - 2030, USD Million
• TABLE 215 Europe Oncology Market by Country, 2019 - 2022, USD Million
• TABLE 216 Europe Oncology Market by Country, 2023 - 2030, USD Million
• TABLE 217 Europe Neurology Market by Country, 2019 - 2022, USD Million
• TABLE 218 Europe Neurology Market by Country, 2023 - 2030, USD Million
• TABLE 219 Europe Immunology Market by Country, 2019 - 2022, USD Million
• TABLE 220 Europe Immunology Market by Country, 2023 - 2030, USD Million
• TABLE 221 Europe Multiomics Market by Country, 2019 - 2022, USD Million
• TABLE 222 Europe Multiomics Market by Country, 2023 - 2030, USD Million
• TABLE 223 Germany Multiomics Market, 2019 - 2022, USD Million
• TABLE 224 Germany Multiomics Market, 2023 - 2030, USD Million
• TABLE 225 Germany Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 226 Germany Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 227 Germany Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 228 Germany Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 229 Germany Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 230 Germany Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 231 Germany Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 232 Germany Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 233 Germany Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 234 Germany Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 235 Germany Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 236 Germany Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 237 UK Multiomics Market, 2019 - 2022, USD Million
• TABLE 238 UK Multiomics Market, 2023 - 2030, USD Million
• TABLE 239 UK Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 240 UK Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 241 UK Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 242 UK Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 243 UK Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 244 UK Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 245 UK Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 246 UK Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 247 UK Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 248 UK Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 249 UK Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 250 UK Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 251 France Multiomics Market, 2019 - 2022, USD Million
• TABLE 252 France Multiomics Market, 2023 - 2030, USD Million
• TABLE 253 France Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 254 France Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 255 France Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 256 France Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 257 France Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 258 France Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 259 France Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 260 France Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 261 France Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 262 France Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 263 France Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 264 France Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 265 Russia Multiomics Market, 2019 - 2022, USD Million
• TABLE 266 Russia Multiomics Market, 2023 - 2030, USD Million
• TABLE 267 Russia Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 268 Russia Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 269 Russia Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 270 Russia Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 271 Russia Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 272 Russia Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 273 Russia Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 274 Russia Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 275 Russia Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 276 Russia Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 277 Russia Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 278 Russia Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 279 Spain Multiomics Market, 2019 - 2022, USD Million
• TABLE 280 Spain Multiomics Market, 2023 - 2030, USD Million
• TABLE 281 Spain Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 282 Spain Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 283 Spain Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 284 Spain Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 285 Spain Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 286 Spain Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 287 Spain Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 288 Spain Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 289 Spain Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 290 Spain Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 291 Spain Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 292 Spain Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 293 Italy Multiomics Market, 2019 - 2022, USD Million
• TABLE 294 Italy Multiomics Market, 2023 - 2030, USD Million
• TABLE 295 Italy Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 296 Italy Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 297 Italy Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 298 Italy Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 299 Italy Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 300 Italy Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 301 Italy Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 302 Italy Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 303 Italy Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 304 Italy Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 305 Italy Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 306 Italy Multiomics Market by Application, 2023 - 2030, USD Million
• TABLE 307 Rest of Europe Multiomics Market, 2019 - 2022, USD Million
• TABLE 308 Rest of Europe Multiomics Market, 2023 - 2030, USD Million
• TABLE 309 Rest of Europe Multiomics Market by Type, 2019 - 2022, USD Million
• TABLE 310 Rest of Europe Multiomics Market by Type, 2023 - 2030, USD Million
• TABLE 311 Rest of Europe Multiomics Market by Product & Service, 2019 - 2022, USD Million
• TABLE 312 Rest of Europe Multiomics Market by Product & Service, 2023 - 2030, USD Million
• TABLE 313 Rest of Europe Multiomics Market by Product Type, 2019 - 2022, USD Million
• TABLE 314 Rest of Europe Multiomics Market by Product Type, 2023 - 2030, USD Million
• TABLE 315 Rest of Europe Multiomics Market by End-use, 2019 - 2022, USD Million
• TABLE 316 Rest of Europe Multiomics Market by End-use, 2023 - 2030, USD Million
• TABLE 317 Rest of Europe Multiomics Market by Platform, 2019 - 2022, USD Million
• TABLE 318 Rest of Europe Multiomics Market by Platform, 2023 - 2030, USD Million
• TABLE 319 Rest of Europe Multiomics Market by Application, 2019 - 2022, USD Million
• TABLE 320 Rest of Europe Multiomics Market by Application, 2023 - 2030, USD Million

The Global Multiomics Market size is expected to reach $5.7 billion by 2030, rising at a market growth of 15.0% CAGR during the forecast period.

Metabolomics aids is understanding how individuals metabolize drugs, which is critical for precision medicine. Thus, Metabolomics segment acquired $215 million in 2022. It can predict drug responses and identify potential adverse reactions, leading to optimized therapeutic strategies. Therefore, these factors will propel the expansion of the metabolomics segment in the upcoming years. Discovering biomarkers linked to many diseases, such as cancer, cardiovascular disease, diabetes, and neurological problems, has become much easier with metabolomics. The identification of disease-specific metabolites holds promise for early diagnosis and personalized treatment.

The major strategies followed by the market participants are Partnerships, Collaborations & Agreements as the key developmental strategy to keep pace with the changing demands of end users. For instance, In January, 2023, Bruker Corporation partnered with Biognosys AG. Under this partnership, both companies would create unique synergies between Biognosys' versatile offerings of proprietary proteomics services, software, and kits, and Bruker's pioneering timsTOF platform. Additionally, In November, 2022, BGI Group signed an agreement with the University of Pecs to launch a joint laboratory in Hungary. Additionally, this world-class facility would hasten the development of genomic sequencing and clinical diagnostic services.

Based on the Analysis presented in the KBV Cardinal matrix; Danaher Corporation and Thermo Fisher Scientific, Inc. are the forerunners in the Market. Companies such as Bruker Corporation, Illumina, Inc. and Becton Dickinson and Company are some of the key innovators in the Market. In January, 2022, Illumina, Inc. partnered with SomaLogic, a protein biomarker discovery and clinical diagnostics company. This partnership aimed to hasten the rapidly growing high throughput sector of the proteomics market.

Market Growth Factors

Rising advancements in high-throughput omics technologies

High-throughput omics technologies have substantially reduced the cost of data generation. This cost-effectiveness has democratized access to multiomics research, making it more affordable for a wider range of researchers, institutions, and companies. As a result, more players are entering the market, fostering innovation and competition. This level of granularity is critical for identifying potential biomarkers and therapeutic targets. The lowered barriers to entry have fostered a thriving ecosystem of start-ups and companies specializing in omics technologies and services. These factors are expected to boost the demand in the future.

Growing demand for personalized medicines worldwide

The emphasis on personalized medicine encourages healthcare providers and researchers to utilize multiomics technologies to a greater extent. This includes genomics, transcriptomics, proteomics, and metabolomics, which provide comprehensive insights into an individual's molecular and genetic makeup. This increased utilization leads to greater demand for multiomics services and solutions. Multiomics data can provide a detailed understanding of a patient's genetic predispositions, biomarker profiles, and disease risks. This integration boosts the demand for multiomics technologies and services. The demand for these data in personalized medicine has created opportunities for innovative start-ups and established companies to provide specialized services and technologies. Thus, these factors will drive the expansion of the market in the upcoming years.

Market Restraining Factors

Continually evolving regulatory environment of multiomics

Data sharing is vital for scientific collaboration and the advancement of multiomics research. However, the need to protect patient privacy and comply with regulations can limit the extent to which data can be shared. This may hinder collaborative research efforts and restrict the availability of multiomics datasets. Regulatory changes can be frequent and unpredictable. Organizations in this market must continuously monitor and adapt to evolving regulations, which can introduce uncertainty into their operations. Regulatory shifts can necessitate changes in data handling, research methodologies, and business models. These factors are expected to limit the growth of this market in the coming years.

Type Outlook

On the basis of type, the market is divided into single-cell multiomics and bulk multiomics. The bulk multiomics segment recorded the maximum revenue share in the market in 2022. The availability of sophisticated bioinformatics tools and data integration platforms has facilitated the analysis and interpretation of bulk multiomics data. Researchers can now perform cross-omics analyses with relative ease, identifying correlations and patterns across different data types. Bulk multiomics plays a pivotal role in the advancement of precision medicine. By analyzing an individual's multiomics profile, clinicians can tailor treatments to their unique molecular characteristics. This approach holds significant promise for improving patient outcomes and reducing adverse effects. Owing to these factors, there will be an increased demand in the bulk multiomics segment.

Product & Service Outlook

Based on product & service, the market is segmented into products and services. In 2022, the services segment garnered a significant revenue share in the market. The continued development of high-throughput omics technologies has made generating vast amounts of data possible. However, analyzing this data requires specialized expertise, leading to a greater reliance on services offered by dedicated providers. Multiomics data is inherently complex, with a multitude of variables and interactions. The interpretation of this data demands sophisticated bioinformatics and computational tools, creating a niche for service providers to offer data analysis and interpretation solutions. These factors are expected to propel the demand in the services segment.

Product Outlook

The product segment is further subdivided into instruments, consumables, and software. In 2022, the instruments subsegment procured the highest revenue share in the market. Next-generation sequencing (NGS) platforms have witnessed remarkable advancements in sequencing capacity, read length, and data quality. These improvements have led to increased adoption of NGS for genomics and transcriptomics studies. Mass spectrometry technology has become more sensitive and capable of analyzing a broader range of molecules. This has expanded its use in proteomics and metabolomics research.

End-use Outlook

On the basis of end-use, the market is divided into academic & research institutes, pharmaceutical & biotechnology companies, and others. The academic and research institutes segment recorded the maximum revenue share in the market in 2022. Academic and research institutes have benefited from the growing availability of research funding from government sources and private foundations. Funding agencies recognize the importance of multiomics research in advancing scientific knowledge and addressing complex health and environmental challenges. This increased funding has allowed academic and research institutions to expand their multiomics research initiatives.

Platform Outlook

Based on platform, the market is segmented into genomics, transcriptomics, proteomics, metabolomics, and integrated omics platforms. The proteomics segment procured a promising growth rate in the market in 2022. Proteomic platforms can determine the functions of proteins, which is crucial for understanding their roles in various biological processes. This information is valuable for basic research and applied sciences. Proteomic analysis can also help in identifying proteins that can serve as therapeutic targets. In industries such as biopharmaceuticals, proteomic platforms are used for quality control to ensure the consistency and safety of products.

Application Outlook

On the basis of application, the market is divided into cell biology, oncology, neurology, and immunology. The cell biology segment recorded the maximum revenue share in the multiomics market in 2022. Cell biology, in conjunction with multiomics, plays a crucial role in cancer research and precision oncology. Researchers can now profile the molecular alterations in cancer cells in unprecedented detail. This has led to the discovery of new drug targets, the development of targeted therapies, and the identification of resistance mechanisms. It also contributes to personalizing cancer treatment regimens, improving patient outcomes. Owing to these factors, the demand will rise in the segment.

Regional Outlook

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America boasts a robust and well-funded research ecosystem with leading universities, academic institutions, and research organizations at the forefront of multiomics studies. These institutions have been driving research, publishing groundbreaking findings, and attracting substantial research funding. Thus, there will be increased demand in the segment.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc, Illumina, Inc., Danaher Corporation, PerkinElmer, Inc., Bruker Corporation, Qiagen N.V., Agilent Technologies, Inc., BGI Group, Becton, Dickinson, and Company, Shimadzu Corporation

Recent Strategies Deployed in Multiomics Market

Partnerships, Collaborations & Agreements

Mar-2023: Illumina Inc. came into partnership with Myriad Genetics Inc., a leader in genetic testing and precision medicine. This partnership aimed to widen access to and availability of oncology homologous recombination deficiency testing in the United States.

Jan-2023: Bruker Corporation partnered with Biognosys AG, a Switzerland-based company. Under this partnership, both companies would create unique synergies between Biognosys' versatile offerings of proprietary proteomics services, software, and kits, and Bruker's pioneering timsTOF platform.

Nov-2022: BGI Group signed an agreement with the University of Pecs, the largest higher education institution in Hungary. This agreement aimed to launch a joint laboratory in Hungary. Additionally, this world-class facility would hasten the development of genomic sequencing and clinical diagnostic services, while empowering BGI Genomics and the UP's leadership in genomics, bioinformatics, reproductive health, and precision medicine in the Central and Eastern European region.

Oct-2022: Illumina Inc. collaborated with AstraZeneca, a global, science-led biopharmaceutical company. This collaboration aimed to hasten drug target discovery by integrating strengths in artificial intelligence-based genome interpretation and genomic analysis techniques along with industry expertise. Additionally, this collaboration would evaluate whether a combined framework of these technologies could increase the yield and confidence of target discovery to find promising drugs based on human omics insights.

Feb-2022: Agilent Technologies Inc. came into partnership with MRM Proteomics, Inc., a biotechnology company. This partnership would offer a complete solution for quantitative protein and metabolite analysis.

Jan-2022: Illumina, Inc. partnered with SomaLogic, a protein biomarker discovery and clinical diagnostics company. This partnership aimed to hasten the rapidly growing high throughput sector of the proteomics market.

Jan-2022: Illumina, Inc. signed an agreement with Nashville Biosciences, LLC, a wholly owned subsidiary of Vanderbilt University Medical Center. This agreement aimed to hasten medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource.

Jun-2021: BGI Group collaborated with Champions Oncology, a leading global oncology data-driven solutions provider. This collaboration aimed to provide mass spectrometry-based proteomics and multiomics data analysis solutions.

Product Launches and Product Expansions

Sep-2023: Bruker Corporation introduced 4D-Proteomics, MALDI HiPLEX-IHC spatial tissue proteomics, 4D-Lipidomics and 4D-Metabolomics. The launched product would perform precise quantification of peptides and proteins present in 100s or 1000s samples by utilizing global retention time and collision cross-section prediction models.

Mar-2023: Illumina Inc. released the novel Illumina Complete Long Read technology, a high-performance, long-read, human whole-genome sequencing assay. The launched product would provide users access to both long- and short-read data on the same Illumina instrument.

Feb-2023: Becton Dickinson and Company reveiled BD Rhapsody HT Xpress System, a new instrument for single-cell multiomics analysis. This product would allow scientists to run high-throughput studies without sacrificing sample integrity potentially accelerating time to discovery across a broad range of disciplines including immunology, genetic disease research, and cancer and chronic disease research.

Jun-2022: Bruker Corporation rolled out the timsTOF HT system, a novel 4th-generation TIMS XR cell and 14-bit digitizer for an even greater dynamic range. The launched product would improve peptide coverage and more accurate quantitation, especially in unbiased 4D plasma and tissue proteomics and epiproteomics.

Mergers & Acquisition

Jan-2022: Bruker Corporation acquired Prolab Instruments GmbH, a Swiss technology company. This acquisition aimed to Augment Multiomics Solutions.

Aug-2021: Illumina, Inc. took over GRAIL, a healthcare company focused on life-saving early detection of multiple cancers. This acquisition aimed to accelerate access and adoption of this life-saving test globally.

Sep-2020: Bruker Corporation took over Canopy Biosciences LLC, a company specializing in high multiplex biomarker imaging for immunology, immuno-oncology, and cell therapy. This acquisition aimed to improve Bruker's portfolios in targeted multi-omics and fluorescence-based imaging techniques.

Geographical Expansions

Aug-2023: Illumina Inc. opened a new facility Illumina Solutions Center in Bengaluru, India. The new facility would support Illumina Inc. to grow the genomics market in India.

Scope of the Study

Market Segments covered in the Report:

By Type

• Bulk Multiomics
• Single-cell Multiomics

By Product & Service

• Product
  • Instruments
  • Consumables
  • Software
• Services

By End-use

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

By Platform

• Genomics
• Transcriptomics
• Proteomics
• Metabolomics
• Integrated Omics Platforms

By Application

• Cell Biology
• Oncology
• Neurology
• Immunology

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Thermo Fisher Scientific, Inc
• Illumina, Inc.
• Danaher Corporation
• PerkinElmer, Inc.
• Bruker Corporation
• Qiagen N.V.
• Agilent Technologies, Inc.
• BGI Group
• Becton, Dickinson, and Company
• Shimadzu Corporation

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Multiomics Market, by Type
  • 1.4.2 Global Multiomics Market, by Product & Service
  • 1.4.3 Global Multiomics Market, by End-use
  • 1.4.4 Global Multiomics Market, by Platform
  • 1.4.5 Global Multiomics Market, by Application
  • 1.4.6 Global Multiomics Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market At a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
  • 4.2.4 Geographical Expansions
• 4.3 Top Winning Strategies
  • 4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
  • 4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jun - 2023, Mar) Leading Players
• 4.4 Porter's Five Force Analysis

Chapter 5. Global Multiomics Market by Type

• 5.1 Global Bulk Multiomics Market by Region
• 5.2 Global Single-cell Multiomics Market by Region

Chapter 6. Global Multiomics Market by Product & Service

• 6.1 Global Product Market by Region
• 6.2 Global Multiomics Market by Product Type
  • 6.2.1 Global Instruments Market by Region
  • 6.2.2 Global Consumables Market by Region
  • 6.2.3 Global Software Market by Region
• 6.3 Global Services Market by Region

Chapter 7. Global Multiomics Market by End-use

• 7.1 Global Academic & Research Institutes Market by Region
• 7.2 Global Pharmaceutical & Biotechnology Companies Market by Region
• 7.3 Global Others Market by Region

Chapter 8. Global Multiomics Market by Platform

• 8.1 Global Genomics Market by Region
• 8.2 Global Transcriptomics Market by Region
• 8.3 Global Proteomics Market by Region
• 8.4 Global Metabolomics Market by Region
• 8.5 Global Integrated Omics Platforms Market by Region

Chapter 9. Global Multiomics Market by Application

• 9.1 Global Cell Biology Market by Region
• 9.2 Global Oncology Market by Region
• 9.3 Global Neurology Market by Region
• 9.4 Global Immunology Market by Region

Chapter 10. Global Multiomics Market by Region

• 10.1 North America Multiomics Market
  • 10.1.1 North America Multiomics Market by Type
    • 10.1.1.1 North America Bulk Multiomics Market by Region
    • 10.1.1.2 North America Single-cell Multiomics Market by Region
  • 10.1.2 North America Multiomics Market by Product & Service
    • 10.1.2.1 North America Product Market by Country
    • 10.1.2.2 North America Multiomics Market by Product Type
      • 10.1.2.2.1 North America Instruments Market by Country
      • 10.1.2.2.2 North America Consumables Market by Country
      • 10.1.2.2.3 North America Software Market by Country
    • 10.1.2.3 North America Services Market by Country
  • 10.1.3 North America Multiomics Market by End-use
    • 10.1.3.1 North America Academic & Research Institutes Market by Country
    • 10.1.3.2 North America Pharmaceutical & Biotechnology Companies Market by Country
    • 10.1.3.3 North America Others Market by Country
  • 10.1.4 North America Multiomics Market by Platform
    • 10.1.4.1 North America Genomics Market by Country
    • 10.1.4.2 North America Transcriptomics Market by Country
    • 10.1.4.3 North America Proteomics Market by Country
    • 10.1.4.4 North America Metabolomics Market by Country
    • 10.1.4.5 North America Integrated Omics Platforms Market by Country
  • 10.1.5 North America Multiomics Market by Application
    • 10.1.5.1 North America Cell Biology Market by Country
    • 10.1.5.2 North America Oncology Market by Country
    • 10.1.5.3 North America Neurology Market by Country
    • 10.1.5.4 North America Immunology Market by Country
  • 10.1.6 North America Multiomics Market by Country
    • 10.1.6.1 US Multiomics Market
      • 10.1.6.1.1 US Multiomics Market by Type
      • 10.1.6.1.2 US Multiomics Market by Product & Service
      • 10.1.6.1.3 US Multiomics Market by End-use
      • 10.1.6.1.4 US Multiomics Market by Platform
      • 10.1.6.1.5 US Multiomics Market by Application
    • 10.1.6.2 Canada Multiomics Market
      • 10.1.6.2.1 Canada Multiomics Market by Type
      • 10.1.6.2.2 Canada Multiomics Market by Product & Service
      • 10.1.6.2.3 Canada Multiomics Market by End-use
      • 10.1.6.2.4 Canada Multiomics Market by Platform
      • 10.1.6.2.5 Canada Multiomics Market by Application
    • 10.1.6.3 Mexico Multiomics Market
      • 10.1.6.3.1 Mexico Multiomics Market by Type
      • 10.1.6.3.2 Mexico Multiomics Market by Product & Service
      • 10.1.6.3.3 Mexico Multiomics Market by End-use
      • 10.1.6.3.4 Mexico Multiomics Market by Platform
      • 10.1.6.3.5 Mexico Multiomics Market by Application
    • 10.1.6.4 Rest of North America Multiomics Market
      • 10.1.6.4.1 Rest of North America Multiomics Market by Type
      • 10.1.6.4.2 Rest of North America Multiomics Market by Product & Service
      • 10.1.6.4.3 Rest of North America Multiomics Market by End-use
      • 10.1.6.4.4 Rest of North America Multiomics Market by Platform
      • 10.1.6.4.5 Rest of North America Multiomics Market by Application
• 10.2 Europe Multiomics Market
  • 10.2.1 Europe Multiomics Market by Type
    • 10.2.1.1 Europe Bulk Multiomics Market by Country
    • 10.2.1.2 Europe Single-cell Multiomics Market by Country
  • 10.2.2 Europe Multiomics Market by Product & Service
    • 10.2.2.1 Europe Product Market by Country
    • 10.2.2.2 Europe Multiomics Market by Product Type
      • 10.2.2.2.1 Europe Instruments Market by Country
      • 10.2.2.2.2 Europe Consumables Market by Country
      • 10.2.2.2.3 Europe Software Market by Country
    • 10.2.2.3 Europe Services Market by Country
  • 10.2.3 Europe Multiomics Market by End-use
    • 10.2.3.1 Europe Academic & Research Institutes Market by Country
    • 10.2.3.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
    • 10.2.3.3 Europe Others Market by Country
  • 10.2.4 Europe Multiomics Market by Platform
    • 10.2.4.1 Europe Genomics Market by Country
    • 10.2.4.2 Europe Transcriptomics Market by Country
    • 10.2.4.3 Europe Proteomics Market by Country
    • 10.2.4.4 Europe Metabolomics Market by Country
    • 10.2.4.5 Europe Integrated Omics Platforms Market by Country
  • 10.2.5 Europe Multiomics Market by Application
    • 10.2.5.1 Europe Cell Biology Market by Country
    • 10.2.5.2 Europe Oncology Market by Country
    • 10.2.5.3 Europe Neurology Market by Country
    • 10.2.5.4 Europe Immunology Market by Country
  • 10.2.6 Europe Multiomics Market by Country
    • 10.2.6.1 Germany Multiomics Market
      • 10.2.6.1.1 Germany Multiomics Market by Type
      • 10.2.6.1.2 Germany Multiomics Market by Product & Service
      • 10.2.6.1.3 Germany Multiomics Market by End-use
      • 10.2.6.1.4 Germany Multiomics Market by Platform
      • 10.2.6.1.5 Germany Multiomics Market by Application
    • 10.2.6.2 UK Multiomics Market
      • 10.2.6.2.1 UK Multiomics Market by Type
      • 10.2.6.2.2 UK Multiomics Market by Product & Service
      • 10.2.6.2.3 UK Multiomics Market by End-use
      • 10.2.6.2.4 UK Multiomics Market by Platform
      • 10.2.6.2.5 UK Multiomics Market by Application
    • 10.2.6.3 France Multiomics Market
      • 10.2.6.3.1 France Multiomics Market by Type
      • 10.2.6.3.2 France Multiomics Market by Product & Service
      • 10.2.6.3.3 France Multiomics Market by End-use
      • 10.2.6.3.4 France Multiomics Market by Platform
      • 10.2.6.3.5 France Multiomics Market by Application
    • 10.2.6.4 Russia Multiomics Market
      • 10.2.6.4.1 Russia Multiomics Market by Type
      • 10.2.6.4.2 Russia Multiomics Market by Product & Service
      • 10.2.6.4.3 Russia Multiomics Market by End-use
      • 10.2.6.4.4 Russia Multiomics Market by Platform
      • 10.2.6.4.5 Russia Multiomics Market by Application
    • 10.2.6.5 Spain Multiomics Market
      • 10.2.6.5.1 Spain Multiomics Market by Type
      • 10.2.6.5.2 Spain Multiomics Market by Product & Service
      • 10.2.6.5.3 Spain Multiomics Market by End-use
      • 10.2.6.5.4 Spain Multiomics Market by Platform
      • 10.2.6.5.5 Spain Multiomics Market by Application
    • 10.2.6.6 Italy Multiomics Market
      • 10.2.6.6.1 Italy Multiomics Market by Type
      • 10.2.6.6.2 Italy Multiomics Market by Product & Service
      • 10.2.6.6.3 Italy Multiomics Market by End-use
      • 10.2.6.6.4 Italy Multiomics Market by Platform
      • 10.2.6.6.5 Italy Multiomics Market by Application
    • 10.2.6.7 Rest of Europe Multiomics Market
      • 10.2.6.7.1 Rest of Europe Multiomics Market by Type
      • 10.2.6.7.2 Rest of Europe Multiomics Market by Product & Service
      • 10.2.6.7.3 Rest of Europe Multiomics Market by End-use
      • 10.2.6.7.4 Rest of Europe Multiomics Market by Platform
      • 10.2.6.7.5 Rest of Europe Multiomics Market by Application
• 10.3 Asia Pacific Multiomics Market
  • 10.3.1 Asia Pacific Multiomics Market by Type
    • 10.3.1.1 Asia Pacific Bulk Multiomics Market by Country
    • 10.3.1.2 Asia Pacific Single-cell Multiomics Market by Country
  • 10.3.2 Asia Pacific Multiomics Market by Product & Service
    • 10.3.2.1 Asia Pacific Product Market by Country
    • 10.3.2.2 Asia Pacific Multiomics Market by Product Type
      • 10.3.2.2.1 Asia Pacific Instruments Market by Country
      • 10.3.2.2.2 Asia Pacific Consumables Market by Country
      • 10.3.2.2.3 Asia Pacific Software Market by Country
    • 10.3.2.3 Asia Pacific Services Market by Country
  • 10.3.3 Asia Pacific Multiomics Market by End-use
    • 10.3.3.1 Asia Pacific Academic & Research Institutes Market by Country
    • 10.3.3.2 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
    • 10.3.3.3 Asia Pacific Others Market by Country
  • 10.3.4 Asia Pacific Multiomics Market by Platform
    • 10.3.4.1 Asia Pacific Genomics Market by Country
    • 10.3.4.2 Asia Pacific Transcriptomics Market by Country
    • 10.3.4.3 Asia Pacific Proteomics Market by Country
    • 10.3.4.4 Asia Pacific Metabolomics Market by Country
    • 10.3.4.5 Asia Pacific Integrated Omics Platforms Market by Country
  • 10.3.5 Asia Pacific Multiomics Market by Application
    • 10.3.5.1 Asia Pacific Cell Biology Market by Country
    • 10.3.5.2 Asia Pacific Oncology Market by Country
    • 10.3.5.3 Asia Pacific Neurology Market by Country
    • 10.3.5.4 Asia Pacific Immunology Market by Country
  • 10.3.6 Asia Pacific Multiomics Market by Country
    • 10.3.6.1 China Multiomics Market
      • 10.3.6.1.1 China Multiomics Market by Type
      • 10.3.6.1.2 China Multiomics Market by Product & Service
      • 10.3.6.1.3 China Multiomics Market by End-use
      • 10.3.6.1.4 China Multiomics Market by Platform
      • 10.3.6.1.5 China Multiomics Market by Application
    • 10.3.6.2 Japan Multiomics Market
      • 10.3.6.2.1 Japan Multiomics Market by Type
      • 10.3.6.2.2 Japan Multiomics Market by Product & Service
      • 10.3.6.2.3 Japan Multiomics Market by End-use
      • 10.3.6.2.4 Japan Multiomics Market by Platform
      • 10.3.6.2.5 Japan Multiomics Market by Application
    • 10.3.6.3 India Multiomics Market
      • 10.3.6.3.1 India Multiomics Market by Type
      • 10.3.6.3.2 India Multiomics Market by Product & Service
      • 10.3.6.3.3 India Multiomics Market by End-use
      • 10.3.6.3.4 India Multiomics Market by Platform
      • 10.3.6.3.5 India Multiomics Market by Application
    • 10.3.6.4 South Korea Multiomics Market
      • 10.3.6.4.1 South Korea Multiomics Market by Type
      • 10.3.6.4.2 South Korea Multiomics Market by Product & Service
      • 10.3.6.4.3 South Korea Multiomics Market by End-use
      • 10.3.6.4.4 South Korea Multiomics Market by Platform
      • 10.3.6.4.5 South Korea Multiomics Market by Application
    • 10.3.6.5 Singapore Multiomics Market
      • 10.3.6.5.1 Singapore Multiomics Market by Type
      • 10.3.6.5.2 Singapore Multiomics Market by Product & Service
      • 10.3.6.5.3 Singapore Multiomics Market by End-use
      • 10.3.6.5.4 Singapore Multiomics Market by Platform
      • 10.3.6.5.5 Singapore Multiomics Market by Application
    • 10.3.6.6 Malaysia Multiomics Market
      • 10.3.6.6.1 Malaysia Multiomics Market by Type
      • 10.3.6.6.2 Malaysia Multiomics Market by Product & Service
      • 10.3.6.6.3 Malaysia Multiomics Market by End-use
      • 10.3.6.6.4 Malaysia Multiomics Market by Platform
      • 10.3.6.6.5 Malaysia Multiomics Market by Application
    • 10.3.6.7 Rest of Asia Pacific Multiomics Market
      • 10.3.6.7.1 Rest of Asia Pacific Multiomics Market by Type
      • 10.3.6.7.2 Rest of Asia Pacific Multiomics Market by Product & Service
      • 10.3.6.7.3 Rest of Asia Pacific Multiomics Market by End-use
      • 10.3.6.7.4 Rest of Asia Pacific Multiomics Market by Platform
      • 10.3.6.7.5 Rest of Asia Pacific Multiomics Market by Application
• 10.4 LAMEA Multiomics Market
  • 10.4.1 LAMEA Multiomics Market by Type
    • 10.4.1.1 LAMEA Bulk Multiomics Market by Country
    • 10.4.1.2 LAMEA Single-cell Multiomics Market by Country
  • 10.4.2 LAMEA Multiomics Market by Product & Service
    • 10.4.2.1 LAMEA Product Market by Country
    • 10.4.2.2 LAMEA Multiomics Market by Product Type
      • 10.4.2.2.1 LAMEA Instruments Market by Country
      • 10.4.2.2.2 LAMEA Consumables Market by Country
      • 10.4.2.2.3 LAMEA Software Market by Country
    • 10.4.2.3 LAMEA Services Market by Country
  • 10.4.3 LAMEA Multiomics Market by End-use
    • 10.4.3.1 LAMEA Academic & Research Institutes Market by Country
    • 10.4.3.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
    • 10.4.3.3 LAMEA Others Market by Country
  • 10.4.4 LAMEA Multiomics Market by Platform
    • 10.4.4.1 LAMEA Genomics Market by Country
    • 10.4.4.2 LAMEA Transcriptomics Market by Country
    • 10.4.4.3 LAMEA Proteomics Market by Country
    • 10.4.4.4 LAMEA Metabolomics Market by Country
    • 10.4.4.5 LAMEA Integrated Omics Platforms Market by Country
  • 10.4.5 LAMEA Multiomics Market by Application
    • 10.4.5.1 LAMEA Cell Biology Market by Country
    • 10.4.5.2 LAMEA Oncology Market by Country
    • 10.4.5.3 LAMEA Neurology Market by Country
    • 10.4.5.4 LAMEA Immunology Market by Country
  • 10.4.6 LAMEA Multiomics Market by Country
    • 10.4.6.1 Brazil Multiomics Market
      • 10.4.6.1.1 Brazil Multiomics Market by Type
      • 10.4.6.1.2 Brazil Multiomics Market by Product & Service
      • 10.4.6.1.3 Brazil Multiomics Market by End-use
      • 10.4.6.1.4 Brazil Multiomics Market by Platform
      • 10.4.6.1.5 Brazil Multiomics Market by Application
    • 10.4.6.2 Argentina Multiomics Market
      • 10.4.6.2.1 Argentina Multiomics Market by Type
      • 10.4.6.2.2 Argentina Multiomics Market by Product & Service
      • 10.4.6.2.3 Argentina Multiomics Market by End-use
      • 10.4.6.2.4 Argentina Multiomics Market by Platform
      • 10.4.6.2.5 Argentina Multiomics Market by Application
    • 10.4.6.3 UAE Multiomics Market
      • 10.4.6.3.1 UAE Multiomics Market by Type
      • 10.4.6.3.2 UAE Multiomics Market by Product & Service
      • 10.4.6.3.3 UAE Multiomics Market by End-use
      • 10.4.6.3.4 UAE Multiomics Market by Platform
      • 10.4.6.3.5 UAE Multiomics Market by Application
    • 10.4.6.4 Saudi Arabia Multiomics Market
      • 10.4.6.4.1 Saudi Arabia Multiomics Market by Type
      • 10.4.6.4.2 Saudi Arabia Multiomics Market by Product & Service
      • 10.4.6.4.3 Saudi Arabia Multiomics Market by End-use
      • 10.4.6.4.4 Saudi Arabia Multiomics Market by Platform
      • 10.4.6.4.5 Saudi Arabia Multiomics Market by Application
    • 10.4.6.5 South Africa Multiomics Market
      • 10.4.6.5.1 South Africa Multiomics Market by Type
      • 10.4.6.5.2 South Africa Multiomics Market by Product & Service
      • 10.4.6.5.3 South Africa Multiomics Market by End-use
      • 10.4.6.5.4 South Africa Multiomics Market by Platform
      • 10.4.6.5.5 South Africa Multiomics Market by Application
    • 10.4.6.6 Nigeria Multiomics Market
      • 10.4.6.6.1 Nigeria Multiomics Market by Type
      • 10.4.6.6.2 Nigeria Multiomics Market by Product & Service
      • 10.4.6.6.3 Nigeria Multiomics Market by End-use
      • 10.4.6.6.4 Nigeria Multiomics Market by Platform
      • 10.4.6.6.5 Nigeria Multiomics Market by Application
    • 10.4.6.7 Rest of LAMEA Multiomics Market
      • 10.4.6.7.1 Rest of LAMEA Multiomics Market by Type
      • 10.4.6.7.2 Rest of LAMEA Multiomics Market by Product & Service
      • 10.4.6.7.3 Rest of LAMEA Multiomics Market by Product Type
      • 10.4.6.7.4 Rest of LAMEA Multiomics Market by End-use
      • 10.4.6.7.5 Rest of LAMEA Multiomics Market by Platform
      • 10.4.6.7.6 Rest of LAMEA Multiomics Market by Application

Chapter 11. Company Profiles

• 11.1 Thermo Fisher Scientific, Inc.
  • 11.1.1 Company Overview
  • 11.1.2 Financial Analysis
  • 11.1.3 Segmental and Regional Analysis
  • 11.1.4 Research & Development Expenses
  • 11.1.5 SWOT Analysis
• 11.2 Illumina, Inc.
  • 11.2.1 Company Overview
  • 11.2.2 Financial Analysis
  • 11.2.3 Segmental and Regional Analysis
  • 11.2.4 Research & Development Expense
  • 11.2.5 Recent strategies and developments:
    • 11.2.5.1 Partnerships, Collaborations, and Agreements:
    • 11.2.5.2 Product Launches and Product Expansions:
    • 11.2.5.3 Acquisition and Mergers:
    • 11.2.5.4 Geographical Expansions:
  • 11.2.6 SWOT Analysis
• 11.3 Danaher Corporation
  • 11.3.1 Company Overview
  • 11.3.2 Financial Analysis
  • 11.3.3 Segmental and Regional Analysis
  • 11.3.4 Research & Development Expense
  • 11.3.5 SWOT Analysis
• 11.4 PerkinElmer, Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Financial Analysis
  • 11.4.3 Segmental and Regional Analysis
  • 11.4.4 Research & Development Expense
  • 11.4.5 SWOT Analysis
• 11.5 Bruker Corporation
  • 11.5.1 Company Overview
  • 11.5.2 Financial Analysis
  • 11.5.3 Segmental and Regional Analysis
  • 11.5.4 Research & Development Expense
  • 11.5.5 Recent strategies and developments:
    • 11.5.5.1 Partnerships, Collaborations, and Agreements:
    • 11.5.5.2 Product Launches and Product Expansions:
    • 11.5.5.3 Acquisition and Mergers:
  • 11.5.6 SWOT Analysis
• 11.6 Qiagen N.V.
  • 11.6.1 Company Overview
  • 11.6.2 Financial Analysis
  • 11.6.3 Regional Analysis
  • 11.6.4 Research & Development Expense
  • 11.6.5 SWOT Analysis
• 11.7 Agilent Technologies, Inc.
  • 11.7.1 Company Overview
  • 11.7.2 Financial Analysis
  • 11.7.3 Segmental and Regional Analysis
  • 11.7.4 Research & Development Expense
  • 11.7.5 Recent strategies and developments:
    • 11.7.5.1 Partnerships, Collaborations, and Agreements:
  • 11.7.6 SWOT Analysis
• 11.8 BGI Group
  • 11.8.1 Company Overview
  • 11.8.2 Recent strategies and developments:
    • 11.8.2.1 Partnerships, Collaborations, and Agreements:
  • 11.8.3 SWOT Analysis
• 11.9 Becton, Dickinson, and Company
  • 11.9.1 Company Overview
  • 11.9.2 Financial Analysis
  • 11.9.3 Segmental and Regional Analysis
  • 11.9.4 Research & Development Expense
    • 11.9.4.1 Product Launches and Product Expansions:
  • 11.9.5 SWOT Analysis
• 11.10. Shimadzu Corporation
  • 11.10.1 Company Overview
  • 11.10.2 Financial Analysis
  • 11.10.3 Segmental and Regional Analysis
  • 11.10.4 Research & Development Expense
  • 11.10.5 SWOT Analysis

Chapter 12. Winning imperative of Multiomics Market